- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**Financial Highlights:** QMS Medical Allied Services reported an operating income of ₹67.57 crore with an EBITDA margin of 18.5% for H1 FY2025. The company continues to strengthen its market position, boasting over 130 institutional customers, including the top 50 pharma companies.
**Strategic Initiatives and Growth Drivers:** QMS has expanded its offerings, emphasizing dual business verticals: Products and Services. The company recently acquired a 51% stake in Saarathi Healthcare, enhancing its patient and disease management capabilities.
**Business Developments:** The company is actively engaging in the hospital sector, expanding its infrastructure for nationwide medical device distribution. It aims to bolster its services by running around 100 preventative screening camps daily, in partnership with pharmaceutical clients.
**Market Position and Competitive Advantage:** Positioned in a rapidly growing healthcare sector, QMS leverages its extensive experience in sourcing and distributing over 900 SKUs to capitalize on the projected value of India's pharma market, estimated at ₹239,600 crore by 2024.
**Investor Implications:** With a progressive strategy focusing on expanding services and enhancing client relationships, QMS presents a positive outlook for growth, particularly in integrating healthcare solutions with pharmaceutical partnerships.